The role of norepinephrine in the treatment of depression.
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D009638:Norepinephrine / Q000502:physiology*; D010919:Placebos; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D009025:Morpholines; D009638:Norepinephrine; D010919:Placebos; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors